Is Ligand Pharmaceuticals (LGND) Still Attractive After Doubling Over The Past Year [Yahoo! Finance]
Ligand Pharmaceuticals Incorporated (LGND)
Last ligand pharmaceuticals incorporated earnings: 2/6 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.ligand.com
Company Research
Source: Yahoo! Finance
If you are wondering whether Ligand Pharmaceuticals at US$199.59 still offers value after a strong run, the key is to understand what the current price actually reflects. The stock has posted a 2.1% return over the last 7 days and 5.0% year to date, with a 100.5% return over 1 year and 173.3% over 3 years, while the 30 day return sits at a 3.2% decline. Recent coverage has focused on how Ligand Pharmaceuticals fits into the broader pharmaceuticals and biotech space, with attention on how its business model and portfolio of assets compare with peers. This context helps frame whether the sharp 1 year and multi year returns align with fundamentals or reflect changing risk perceptions. On Simply Wall St's valuation checks, the company scores 4 out of 6 . This sets up a closer look at traditional metrics like P/E and cash flow based models, and also a later discussion on a more complete way to think about valuation beyond a single score. Ligand Pharmaceuticals delivered 100.5% ret
Show less
Read more
Impact Snapshot
Event Time:
LGND
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LGND alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LGND alerts
High impacting Ligand Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
LGND
News
- CLO Sells LGND 5,000 Shares for $1.0 Million [Yahoo! Finance]Yahoo! Finance
- Neuroblastoma Market Analysis Report 2026-2030 | Rising Childhood Cancer Incidence Fuels Demand | Identify Lucrative Growth Segments for Investment Purposes [Yahoo! Finance]Yahoo! Finance
- Ligand Pharma CFO Sells $688K in Stock as Shares Surge 80% This Past Year. Here's What to Know [Yahoo! Finance]Yahoo! Finance
- Ligand Advances Strategic Growth with Expanded and Strengthened Business Development TeamGlobeNewswire
- Ligand Pharmaceuticals (LGND) had its price target raised by Citigroup Inc. from $270.00 to $276.00. They now have a "buy" rating on the stock.MarketBeat
LGND
Earnings
- 2/26/26 - Beat
LGND
Sec Filings
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- 4/1/26 - Form 144
- LGND's page on the SEC website